| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ion channel regulator activity | 2.27e-03 | 162 | 9 | 2 | GO:0099106 | |
| GeneOntologyMolecularFunction | channel regulator activity | 2.61e-03 | 174 | 9 | 2 | GO:0016247 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 2.70e-03 | 177 | 9 | 2 | GO:0141108 | |
| Domain | Bromodomain_CS | 5.19e-05 | 26 | 8 | 2 | IPR018359 | |
| Domain | BROMODOMAIN_1 | 1.06e-04 | 37 | 8 | 2 | PS00633 | |
| Domain | Bromodomain | 1.12e-04 | 38 | 8 | 2 | PF00439 | |
| Domain | BROMODOMAIN_2 | 1.31e-04 | 41 | 8 | 2 | PS50014 | |
| Domain | Bromodomain | 1.37e-04 | 42 | 8 | 2 | IPR001487 | |
| Domain | - | 1.37e-04 | 42 | 8 | 2 | 1.20.920.10 | |
| Domain | BROMO | 1.37e-04 | 42 | 8 | 2 | SM00297 | |
| Domain | - | 1.47e-02 | 449 | 8 | 2 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 1.53e-02 | 459 | 8 | 2 | IPR013083 | |
| Pubmed | Enoyl-CoA hydratase-1 regulates mTOR signaling and apoptosis by sensing nutrients. | 6.76e-06 | 14 | 10 | 2 | 28878358 | |
| Pubmed | 2.04e-04 | 75 | 10 | 2 | 25593309 | ||
| Interaction | HSP90AB1 interactions | 5.01e-05 | 960 | 10 | 5 | int:HSP90AB1 | |
| Interaction | ASB18 interactions | 7.73e-05 | 27 | 10 | 2 | int:ASB18 | |
| Interaction | HADHA interactions | 1.14e-04 | 567 | 10 | 4 | int:HADHA | |
| Interaction | STAC3 interactions | 1.98e-04 | 43 | 10 | 2 | int:STAC3 | |
| Interaction | ERH interactions | 2.00e-04 | 245 | 10 | 3 | int:ERH | |
| Interaction | ECHS1 interactions | 2.30e-04 | 257 | 10 | 3 | int:ECHS1 | |
| Interaction | BAZ2B interactions | 3.49e-04 | 57 | 10 | 2 | int:BAZ2B | |
| Interaction | CDKL2 interactions | 5.41e-04 | 71 | 10 | 2 | int:CDKL2 | |
| Interaction | TMEM160 interactions | 5.56e-04 | 72 | 10 | 2 | int:TMEM160 | |
| Interaction | CST11 interactions | 6.03e-04 | 75 | 10 | 2 | int:CST11 | |
| Interaction | PRDX1 interactions | 7.18e-04 | 379 | 10 | 3 | int:PRDX1 | |
| Interaction | EPB41L4B interactions | 8.11e-04 | 87 | 10 | 2 | int:EPB41L4B | |
| Interaction | MCPH1 interactions | 1.09e-03 | 101 | 10 | 2 | int:MCPH1 | |
| Interaction | FRS2 interactions | 1.11e-03 | 102 | 10 | 2 | int:FRS2 | |
| Interaction | KIF1A interactions | 1.11e-03 | 102 | 10 | 2 | int:KIF1A | |
| Interaction | CSNK2A3 interactions | 1.29e-03 | 110 | 10 | 2 | int:CSNK2A3 | |
| Interaction | ARK2N interactions | 1.43e-03 | 116 | 10 | 2 | int:ARK2N | |
| Interaction | HUWE1 interactions | 1.47e-03 | 1110 | 10 | 4 | int:HUWE1 | |
| Interaction | HLA-G interactions | 1.48e-03 | 118 | 10 | 2 | int:HLA-G | |
| Interaction | MAP2K5 interactions | 1.53e-03 | 120 | 10 | 2 | int:MAP2K5 | |
| Interaction | CHD1 interactions | 1.72e-03 | 127 | 10 | 2 | int:CHD1 | |
| Interaction | HMBOX1 interactions | 1.82e-03 | 131 | 10 | 2 | int:HMBOX1 | |
| Interaction | CXXC1 interactions | 1.85e-03 | 132 | 10 | 2 | int:CXXC1 | |
| Interaction | LLGL2 interactions | 1.88e-03 | 133 | 10 | 2 | int:LLGL2 | |
| Interaction | DNAJA1 interactions | 1.92e-03 | 533 | 10 | 3 | int:DNAJA1 | |
| Interaction | TBC1D4 interactions | 1.94e-03 | 135 | 10 | 2 | int:TBC1D4 | |
| Interaction | CAMSAP3 interactions | 2.02e-03 | 138 | 10 | 2 | int:CAMSAP3 | |
| Interaction | AP3S1 interactions | 2.11e-03 | 141 | 10 | 2 | int:AP3S1 | |
| Interaction | GABARAP interactions | 2.23e-03 | 145 | 10 | 2 | int:GABARAP | |
| Interaction | IRS1 interactions | 2.23e-03 | 145 | 10 | 2 | int:IRS1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p36 | 9.14e-03 | 681 | 10 | 2 | chr1p36 | |
| Coexpression | GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP | 3.17e-05 | 171 | 10 | 3 | M2947 | |
| Coexpression | GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_UP | 5.05e-05 | 200 | 10 | 3 | M4576 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.00e-05 | 199 | 10 | 3 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Intermediate|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 2.58e-04 | 109 | 10 | 2 | 48f675d36fece070410eb9cfe64805f4629e290f | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.67e-04 | 130 | 10 | 2 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 5.35e-04 | 157 | 10 | 2 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.35e-04 | 157 | 10 | 2 | 9665a1375cfd8e9b8781c852686591226c0e0d9a | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.55e-04 | 160 | 10 | 2 | 0293b244c063a62819690bf22bbc2681f8d15252 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 5.55e-04 | 160 | 10 | 2 | 3eaae86fa08f7651021316f8e5811bf48055591e | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 5.76e-04 | 163 | 10 | 2 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | 390C-Lymphocytic-ILC|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.83e-04 | 164 | 10 | 2 | b0fc63b72162b5cc4d1e0a271a12f3d3ab29398f | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-NK_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 5.97e-04 | 166 | 10 | 2 | b041010038a570ad929812f35514cb54e4f68f66 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-type_I_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-04 | 166 | 10 | 2 | 11b0ae82b3068ef91715dbdd49fe8e9791b4a480 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.97e-04 | 166 | 10 | 2 | fcc1aec31ebd39432d4cb284dc8fadf34e3c566a | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-BM_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-04 | 167 | 10 | 2 | d30b96c39da3dd02500443877a4eb3500e26802c | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.04e-04 | 167 | 10 | 2 | 713899690e4acd9d259645e363c26983d6ef3022 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-2|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.12e-04 | 168 | 10 | 2 | 2781dd6b369427a94c5059b44b4c8f023f5f2988 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-club_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.26e-04 | 170 | 10 | 2 | 6de3778e8257c3330db0780c59238ca501fe5059 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.26e-04 | 170 | 10 | 2 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-club_cell-club_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.26e-04 | 170 | 10 | 2 | 60887da674ef1a735bad618235608312d8de63d3 | |
| ToppCell | 390C-Lymphocytic-ILC|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.33e-04 | 171 | 10 | 2 | 70963f79711fe6088d6d01b29206b17ab89e5e73 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.41e-04 | 172 | 10 | 2 | a9e13aa36087170dadca421ba9de588e5a1cf715 | |
| ToppCell | 390C-Lymphocytic-ILC-ILC-2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 6.41e-04 | 172 | 10 | 2 | 84d16cd7f618c94888920680bdc9e7130d73fd75 | |
| ToppCell | AT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 6.48e-04 | 173 | 10 | 2 | 3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.63e-04 | 175 | 10 | 2 | f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 6.63e-04 | 175 | 10 | 2 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-04 | 177 | 10 | 2 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-04 | 177 | 10 | 2 | 164ffbbf798defa3728197deb1a14b661490e525 | |
| ToppCell | Control-Epithelial_alveolar-AT_1-Differentiating_AT1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-04 | 177 | 10 | 2 | 9af14a056eb6d88c6f11b09f6d4c0d3448d647d5 | |
| ToppCell | Control-Epithelial_alveolar-AT_1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.86e-04 | 178 | 10 | 2 | aa7d43c655df493f1330a5001efaa484e4a19f69 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.86e-04 | 178 | 10 | 2 | b3b88989bd602cfb55bb5c47731deb99288a8952 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.86e-04 | 178 | 10 | 2 | a3af5d9c55858e36be0498081029ecb0acaeb3d3 | |
| ToppCell | metastatic_Brain-T/NK_cells-Exhausted_Tfh|T/NK_cells / Location, Cell class and cell subclass | 6.86e-04 | 178 | 10 | 2 | 9a3581a0158dfa5a1cc942f8c532afb5e38b272a | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.86e-04 | 178 | 10 | 2 | c90e9048fc786ba8559972ae25c25ecab4bc1b7c | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.86e-04 | 178 | 10 | 2 | 9e426ce23a4a33b91d139ad85685cf8483bcd01a | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.86e-04 | 178 | 10 | 2 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.94e-04 | 179 | 10 | 2 | cb38b54261a7af5ee3347e64c8aa880a77ed0763 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.94e-04 | 179 | 10 | 2 | 04ce3673e46606f63d9c87bcba3a64c96817d812 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.94e-04 | 179 | 10 | 2 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 6.94e-04 | 179 | 10 | 2 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.94e-04 | 179 | 10 | 2 | d5763912a4ce7188535675e338799b856edb9dda | |
| ToppCell | AT1_cells-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 7.01e-04 | 180 | 10 | 2 | 2d52cb5f77dde0e3dccac1333d4ec67ec680fcb2 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.09e-04 | 181 | 10 | 2 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_naive-2|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.09e-04 | 181 | 10 | 2 | 75035a3211e524bb659b82e6979f7d3a3121ae70 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.17e-04 | 182 | 10 | 2 | cc79e0cc21e2fdc4ef77f052818d27b9f707aec1 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.25e-04 | 183 | 10 | 2 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | IPF-Epithelial-ATI|World / Disease state, Lineage and Cell class | 7.25e-04 | 183 | 10 | 2 | 31fef35ecf30162662f24d335d8f0cceacc07039 | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 7.25e-04 | 183 | 10 | 2 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | COVID-19-lung-AT1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.25e-04 | 183 | 10 | 2 | 7b1a385ed54f93bfe85bf0c162e42d05d516b45c | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.25e-04 | 183 | 10 | 2 | 274483009b309289e4cb84beedf6806430db6ff6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.33e-04 | 184 | 10 | 2 | 29c95b814a0b1ad8734ed68b77df29c08594e5ec | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.33e-04 | 184 | 10 | 2 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| ToppCell | P28-Epithelial|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.33e-04 | 184 | 10 | 2 | 05811d13bd8a602095a3fcf5e55345edadc7b8bf | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.33e-04 | 184 | 10 | 2 | cdf6f1c6cce97a7effa0c55959652e2c0b6992b3 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 7.33e-04 | 184 | 10 | 2 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 7.33e-04 | 184 | 10 | 2 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.33e-04 | 184 | 10 | 2 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.33e-04 | 184 | 10 | 2 | 7cc5796557379c3d1db078c1aeda40659c6e401c | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.33e-04 | 184 | 10 | 2 | 42ce855b4f8475a8298192feec785bdc69bc5bb0 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.33e-04 | 184 | 10 | 2 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.41e-04 | 185 | 10 | 2 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | Control-Epithelial-ATI|World / Disease state, Lineage and Cell class | 7.41e-04 | 185 | 10 | 2 | 0563d5042bb96ecce8446fbf26d05ef7a45e23c5 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-04 | 185 | 10 | 2 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.41e-04 | 185 | 10 | 2 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.41e-04 | 185 | 10 | 2 | 5bb513e569f3a197d55ae2ca683e202daebabeac | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-AT1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.41e-04 | 185 | 10 | 2 | 0c247a3f394c42e2a6f67fee3d9cf33096fecd13 | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 7.48e-04 | 186 | 10 | 2 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.48e-04 | 186 | 10 | 2 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | Control-Epithelial-Club|World / Disease state, Lineage and Cell class | 7.48e-04 | 186 | 10 | 2 | 9798428691408e17ff2af2fe2d1b345f074d67e4 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-04 | 186 | 10 | 2 | f23f21781a758541f59c06efa7739d26a03fb478 | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-04 | 186 | 10 | 2 | 0de87109da9324c597fadf2eb782f0f158afe832 | |
| ToppCell | P15-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.48e-04 | 186 | 10 | 2 | 521e6e007bbae73e7328153aa170cf04ca3c1093 | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-04 | 186 | 10 | 2 | 8fc0487fc1b2fd403bd7c257fcabbff652f971c9 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.48e-04 | 186 | 10 | 2 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.56e-04 | 187 | 10 | 2 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.56e-04 | 187 | 10 | 2 | ff26a533d310126521efe1d05cf8b9d32e524550 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 7.56e-04 | 187 | 10 | 2 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | P28-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.56e-04 | 187 | 10 | 2 | a4b41904ba05eb76212c949fc3ac197f906c8351 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD79a_B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.56e-04 | 187 | 10 | 2 | b51af2824e65734f333b1325117f4a2e88b17c23 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.56e-04 | 187 | 10 | 2 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 7.56e-04 | 187 | 10 | 2 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.65e-04 | 188 | 10 | 2 | 43a0508d2524a5b310e89e9422843dcaab999bc3 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 7.65e-04 | 188 | 10 | 2 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | MS-CD8-CD4_Treg|MS / Condition, Cell_class and T cell subcluster | 7.65e-04 | 188 | 10 | 2 | 2f0e2c7d79ee2d69a5d908c0247dc950c056c30a | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 7.65e-04 | 188 | 10 | 2 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | IPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class | 7.73e-04 | 189 | 10 | 2 | f3fcef008ef252b29ac6d567fef27f9acf9cd70f | |
| ToppCell | COVID-19-lung-AT2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.81e-04 | 190 | 10 | 2 | 27a1a86620fe9b5ee930d388b32352206485e6d0 | |
| ToppCell | E17.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.81e-04 | 190 | 10 | 2 | 15f314517ed47b12d287a12a7d18cb383310e25a | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 7.89e-04 | 191 | 10 | 2 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | LAM-Epithelial-AT1|LAM / Condition, Lineage and Cell class | 7.89e-04 | 191 | 10 | 2 | 66875b2ec2c510489407f3e433a90cdf74a15094 | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 7.89e-04 | 191 | 10 | 2 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | P07-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.89e-04 | 191 | 10 | 2 | 0f360766490bef3495c42f6421b22a988cfc68fb | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 7.89e-04 | 191 | 10 | 2 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.89e-04 | 191 | 10 | 2 | 63aa671837b79d2feb7ed1e67712cc01caf72bef | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.89e-04 | 191 | 10 | 2 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.89e-04 | 191 | 10 | 2 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | P03-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.97e-04 | 192 | 10 | 2 | be5e246b2350398b985767b2fbede17a8dd8cc44 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 7.97e-04 | 192 | 10 | 2 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 7.97e-04 | 192 | 10 | 2 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Control-Epithelial-Club|Control / Disease state, Lineage and Cell class | 7.97e-04 | 192 | 10 | 2 | d84ed1ea4a03edaa18c804f75afb03bd7b1f0e16 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.97e-04 | 192 | 10 | 2 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-Dividing_AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.05e-04 | 193 | 10 | 2 | 44839a606ae2f8e37421bda46d588189e1c943d2 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ARRRRLYWGFFSGRG | 176 | Q96L58 | |
| RYRRRYWILPQCGGI | 1381 | Q9UIF8 | |
| YGRLIHRVRYRRGLW | 331 | A0A1B0GVH7 | |
| LYRQRRSGRAWYLGL | 161 | Q92914 | |
| GMGRGYRQRWRLQGR | 66 | Q494R0 | |
| GRYHRGGYRPVWNRR | 86 | Q9NYF8 | |
| YGLRRWNGRRLRTYG | 2091 | Q9NSI6 | |
| RRFRSRYWSPGRGGR | 586 | P37088 | |
| VRLWRGCGFGYRYTR | 971 | Q5XPI4 | |
| RRGARRWRKLYRANG | 116 | Q05513 |